Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
World Journal of Surgery
Published in: World Journal of Surgery 10/2009

01-10-2009

Gastroesophageal Reflux Disease and Morbid Obesity: Is There a Relation?

Authors: Piero M. Fisichella, Marco G. Patti

Published in: World Journal of Surgery | Issue 10/2009

Login to get access

Abstract

Gastroesophageal reflux disease (GERD) is highly prevalent in morbidly obese patients, and a high body mass index (BMI) is a risk factor for the development of GERD. However, the mechanism by which the BMI affects esophageal acid exposure is not completely understood. Although many advances have been made in the understanding of the pathophysiology of GERD, many aspects of the pathophysiology of this disease in morbidly obese patients remain unclear. The following review describes the current evidence linking esophageal reflux to obesity, covering the pathophysiology of the disease and the implications for treatment of GERD in the obese patient.
Literature
1.
Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295:1549–1555PubMedCrossRef
2.
Dent J, El-Serag HB, Wallander MA, Johansson S (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54:710–717PubMedCrossRef
3.
Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (1999) Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106:642–649PubMedCrossRef
4.
Murray L, Johnston B, Lane A, Harvey I, Donovan J, Nair P, Harvey R (2003) Relationship between body mass and gastro-oesophageal reflux symptoms: the Bristol Helicobacter Project. Int J Epidemiol 32:645–650PubMedCrossRef
5.
El-Serag HB, Tran T, Richardson P, Ergun G (2006) Anthropometric correlates of intragastric pressure. Scand J Gastroenterol 41:887–891PubMedCrossRef
6.
Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ (2006) Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 130:639–649PubMedCrossRef
7.
Merrouche M, Sabaté JM, Jouet P, Harnois F, Scaringi S, Coffin B, Msika S (2007) Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients before and after bariatric surgery. Obes Surg 17:894–900PubMedCrossRef
8.
Wu JC, Mui LM, Cheung CM, Chan Y, Sung JJ (2007) Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology 132:883–889PubMedCrossRef
9.
El-Serag HB, Graham DY, Satia JA, Rabeneck L (2005) Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 100:1243–1250PubMedCrossRef
10.
Stein DJ, El-Serag HB, Kuczynski J, Kramer JR, Sampliner RE (2005) The association of body mass index with Barrett’s oesophagus. Aliment Pharmacol Ther 22:1005–1010PubMedCrossRef
11.
Hampel H, Abraham NS, El-Serag HB (2005) Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143:199–211PubMed
12.
Herbella FA, Sweet MP, Tedesco P, Nipomnick I, Patti MG (2007) Gastroesophageal reflux disease and obesity: pathophysiology and implications for treatment. J Gastrointest Surg 11:286–290PubMedCrossRef
13.
Lane JA, Harvey RF, Murray LJ, Harvey IM, Donovan JL, Nair P, Egger M (2002) A placebo-controlled randomized trial of eradication of Helicobacter pylori in the general population: study design and response rates of the Bristol Helicobacter Project. Control Clin Trials 23:321–332PubMedCrossRef
14.
Abnet CC, Freedman ND, Hollenbeck AR, Fraumeni JF Jr, Leitzmann M, Schatzkin A (2008) A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. Eur J Cancer 44:465–471PubMedCrossRef
15.
Ryan AM, Healy LA, Power DG, Byrne M, Murphy S, Byrne PJ, Kelleher D, Reynolds JV (2008) Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state. Ann Surg 247:909–915PubMedCrossRef
16.
Melstrom LG, Bentrem DJ, Salvino MJ, Blum MG, Talamonti MS, Printen KJ (2008) Adenocarcinoma of the gastroesophageal junction after bariatric surgery. Am J Surg 196:135–138PubMedCrossRef
17.
Allen JW, Leeman MF, Richardson JD (2004) Esophageal carcinoma following bariatric procedures. JSLS 8:372–375PubMed
18.
Sugerman HJ (2001) Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am 81:1063–1075PubMedCrossRef
19.
El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR (2007) Obesity increases oesophageal acid exposure. Gut 56:749–755PubMedCrossRef
20.
Patti MG, Goldberg HI, Arcerito M, Bortolasi L, Tong J, Way LW (1996) Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg 171:182–186PubMedCrossRef
21.
Zaninotto G, DeMeester TR, Schwizer W, Johansson KE, Cheng SC (1988) The lower esophageal sphincter in health and disease. Am J Surg 155:104–111PubMedCrossRef
22.
Diener U, Patti MG, Molena D, Fisichella PM, Way LW (2001) Esophageal dysmotility and gastroesophageal reflux disease. J Gastrointest Surg 5:260–265PubMedCrossRef
23.
Kahrilas PJ, Dodds WJ, Hogan WJ, Kern M, Arndorfer RC, Reece A (1986) Esophageal peristaltic dysfunction in peptic esophagitis. Gastroenterology 91:897–904PubMed
24.
Di Francesco V, Baggio E, Mastromauro M, Zoico E, Stefenelli N, Zamboni M, Panourgia MP, Frulloni L, Bovo P, Bosello O, Cavallini G (2004) Obesity and gastro-esophageal acid reflux: physiopathological mechanisms and role of gastric bariatric surgery. Obes Surg 14:1095–1102PubMedCrossRef
25.
Suter M, Dorta G, Giusti V, Calmes JM (2004) Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients. Obes Surg 14:959–966PubMedCrossRef
26.
Weiss HG, Nehoda H, Labeck B, Peer-Kühberger MD, Klingler P, Gadenstätter M, Aigner F, Wetscher GJ (2000) Treatment of morbid obesity with laparoscopic adjustable gastric banding affects esophageal motility. Am J Surg 180:479–482PubMedCrossRef
27.
Fraser J, Watson DI, O’Boyle CJ, Jamieson GG (2001) Obesity and its effect on outcome of laparoscopic Nissen fundoplication. Dis Esophagus 14:50–53PubMedCrossRef
28.
Winslow ER, Frisella MM, Soper NJ, Klingensmith ME (2003) Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS). Surg Endosc 17:2003–2011PubMedCrossRef
29.
Anvari M, Bamehriz F (2006) Outcome of laparoscopic Nissen fundoplication in patients with body mass index > or = 35. Surg Endosc 20:230–234PubMedCrossRef
30.
D’Alessio MJ, Arnaoutakis D, Giarelli N, Villadolid DV, Rosemurgy AS (2005) Obesity is not a contraindication to laparoscopic Nissen fundoplication. J Gastrointest Surg 9:949–954PubMedCrossRef
31.
Perez AR, Moncure AC, Rattner DW (2001) Obesity adversely affects the outcome of antireflux operations. Surg Endosc 15:986–989PubMedCrossRef
32.
Morgenthal CB, Lin E, Shane MD, Hunter JG, Smith CD (2007) Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes. Surg Endosc 21:1978–1984PubMedCrossRef
33.
Frezza EE, Ikramuddin S, Gourash W, Rakitt T, Kingston A, Luketich J, Schauer P (2002) Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass. Surg Endosc 16:1027–1031PubMedCrossRef
34.
Patterson EJ, Davis DG, Khajanchee Y, Swanström LL (2003) Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn. Surg Endosc 17:1561–1565PubMedCrossRef
35.
Csendes A, Burgos AM, Smok G, Burdiles P, Henriquez A (2006) Effect of gastric bypass on Barrett’s esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg 10:259–264PubMedCrossRef
Metadata
Title
Gastroesophageal Reflux Disease and Morbid Obesity: Is There a Relation?
Authors
Piero M. Fisichella
Marco G. Patti
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 10/2009
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-009-0045-z

Other articles of this Issue 10/2009

World Journal of Surgery 10/2009 Go to the issue

OriginalPaper

Metastasis of Right Upper Para-Esophageal Lymph Nodes in Central Compartment Lymph Node Dissection of Papillary Thyroid Cancer

OriginalPaper

The Role of Malabsorption in Bariatric Surgery

OriginalPaper

Value of Routine Histopathologic Examination of Three Common Surgical Specimens: Appendix, Gallbladder, and Hemorrhoid

OriginalPaper

Predictors of Length of Stay Following Colorectal Resection for Neoplasms in 183 Veterans Affairs Patients

OriginalPaper

Initial Management of Extensive Mesenteric Venous Thrombosis: Retrospective Study of Nine Cases

OriginalPaper

Minimally Invasive Surgical Treatment of Hepatocellular Carcinoma: Long-Term Outcome